These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24014073)
21. The role of genetics in inhibitor formation. Gill JC Thromb Haemost; 1999 Aug; 82(2):500-4. PubMed ID: 10605742 [TBL] [Abstract][Full Text] [Related]
22. [Hemophilic patients. Treatment protocol in the dental office]. Kouvelas N; Vierrou AM Hell Stomatol Chron; 1988; 32(3):221-7. PubMed ID: 2978976 [TBL] [Abstract][Full Text] [Related]
23. The multifactorial etiology of inhibitor development in hemophilia: genetics and environment. Gouw SC; van den Berg HM Semin Thromb Hemost; 2009 Nov; 35(8):723-34. PubMed ID: 20169509 [TBL] [Abstract][Full Text] [Related]
24. The Pennsylvania hemophilia program 1973-1978. Eyster ME; Lewis JH; Shapiro SS; Gill F; Kajani M; Prager D; Djerassi I; Rice S; Lusch C; Keller A Am J Hematol; 1980; 9(3):277-86. PubMed ID: 6786095 [TBL] [Abstract][Full Text] [Related]
25. Frequency of congenital heart defects in patients with hemophilia. Jedele KB; Michels VV; Gordon H; Gilchrist GS Am J Med Genet; 1990 Jul; 36(3):333-5. PubMed ID: 2363433 [TBL] [Abstract][Full Text] [Related]
26. [Molecular diagnosis in patients and carriers of hemophilia A and B]. Mantilla-Capacho J; Beltrán-Miranda CP; Jaloma-Cruz AR Gac Med Mex; 2005; 141(1):69-71. PubMed ID: 15754755 [No Abstract] [Full Text] [Related]
27. [The interest in and difficulties with the biological assay of hemophilia A and B carriers]. Favre-Gilly J; Thouverez JP; Belleville J; Croizat P Bibl Haematol; 1966; 26():54-7. PubMed ID: 5955565 [No Abstract] [Full Text] [Related]
28. Future characteristics of bypassing agents to improve care of hemophilia inhibitor patients: an economic and health-related quality of life perspective. Weatherall J; Barnes N; Brown C; Préaud E Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):411-4. PubMed ID: 21831021 [TBL] [Abstract][Full Text] [Related]
29. Old and new challenges in hemophilia management. Coppola A; Tagliaferri A; Franchini M Semin Thromb Hemost; 2013 Oct; 39(7):693-6. PubMed ID: 24065578 [No Abstract] [Full Text] [Related]
30. [Gene mutation and gene diagnosis of hemophilia]. Kojima T Nihon Seirigaku Zasshi; 1998; 60(1):31-42. PubMed ID: 9614303 [No Abstract] [Full Text] [Related]
31. Hemophilia B Leyden and a similar variant of hemophilia A. Ljung R; Nilsson IM N Engl J Med; 1982 Sep; 307(14):897-8. PubMed ID: 7110269 [No Abstract] [Full Text] [Related]
32. [A new therapy of hemophilia with ranitidine]. Hu LM; Ye LL; Xu B Zhonghua Nei Ke Za Zhi; 1990 Feb; 29(2):85-7, 125. PubMed ID: 2120016 [TBL] [Abstract][Full Text] [Related]
33. Importance of pharmacokinetics in the management of hemophilia. Barnes C Pediatr Blood Cancer; 2013; 60 Suppl 1():S27-9. PubMed ID: 23109436 [TBL] [Abstract][Full Text] [Related]
34. Increased bone resorption in hemophilia. Rodriguez-Merchan EC; Valentino LA Blood Rev; 2019 Jan; 33():6-10. PubMed ID: 29857920 [TBL] [Abstract][Full Text] [Related]
36. [Genetic questions of hemophilia]. Weissbach G; Lenk H Z Gesamte Inn Med; 1981 Jun; 36(11):363-70. PubMed ID: 6795839 [TBL] [Abstract][Full Text] [Related]
37. [Genetic aspects of hemophilia A and B]. Veltkamp JJ Ned Tijdschr Geneeskd; 1975 Jan; 119(1):17-22. PubMed ID: 1088978 [No Abstract] [Full Text] [Related]
38. [Physiopathology and therapy of hemophilia and von Willebrand's disease]. Fukui H Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):866-74. PubMed ID: 1919201 [No Abstract] [Full Text] [Related]
39. [Classification of hemophilia B and detection of its carriers]. Takamatsu J; Kamiya T Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):943-51. PubMed ID: 7158256 [No Abstract] [Full Text] [Related]